ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intelligent Drug R-D Services Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-28C13766
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Intelligent Drug R D Services Market Research Report 2023
BUY CHAPTERS

Global Intelligent Drug R-D Services Market Research Report 2025

Code: QYRE-Auto-28C13766
Report
May 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BenevolentAI
Exscientia Ltd
IBM
Alphabet
Berg Health
Atomwise
Insitro
Cyclica Inc
NVidia
InSilico Medicine
Astrazeneca plc
Capgemini Engineering
XtalPi
Schrödinger
Charles River Laboratories
IQVIA
Healx
Innoplexus
Icometrix
Hafnium Labs ApS
EVAXION BIOTECH A/S

Intelligent Drug R-D Services Market Size

The global market for Intelligent Drug R-D Services was valued at US$ 1823 million in the year 2024 and is projected to reach a revised size of US$ 10370 million by 2031, growing at a CAGR of 28.6% during the forecast period.

Intelligent Drug R-D Services Market

Intelligent Drug R-D Services Market

Leading biopharmaceutical companies believe in AI due to growing awareness in the pharmaceutical sector and rising investment in drug development. AI works with the latest advanced biology and chemistry processes to develop state-of-the-art algorithms; it has the potential to move drug screening from the bench to a virtual lab without the need for extensive experimental input and manpower.Most biopharmaceutical companies have started internal programs or are collaborating to develop AI platforms for increasing the research power of immuno-oncology drugs, metabolic-disease therapies, cancer treatments, and many other therapeutic targets.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intelligent Drug R-D Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intelligent Drug R-D Services.
The Intelligent Drug R-D Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intelligent Drug R-D Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intelligent Drug R-D Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Intelligent Drug R-D Services Market Report

Report Metric Details
Report Name Intelligent Drug R-D Services Market
Accounted market size in year US$ 1823 million
Forecasted market size in 2031 US$ 10370 million
CAGR 28.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Cloud Based
  • On-Premise
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BenevolentAI, Exscientia, IBM, Alphabet, Berg Health, Atomwise, Insitro, Cyclica, NVIDIA, Insilico Medicine, AstraZeneca, CAPGEMINI ENGINEERING, Hafnium Labs ApS, XtalPi Inc, Schrödinger, Charles River Laboratories, IQVIA Inc, Healx, Innoplexus, EVAXION BIOTECH A/S, Icometrix
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Intelligent Drug R-D Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Intelligent Drug R-D Services Market growing?

Ans: The Intelligent Drug R-D Services Market witnessing a CAGR of 28.6% during the forecast period 2025-2031.

What is the Intelligent Drug R-D Services Market size in 2031?

Ans: The Intelligent Drug R-D Services Market size in 2031 will be US$ 10370 million.

Who are the main players in the Intelligent Drug R-D Services Market report?

Ans: The main players in the Intelligent Drug R-D Services Market are BenevolentAI, Exscientia, IBM, Alphabet, Berg Health, Atomwise, Insitro, Cyclica, NVIDIA, Insilico Medicine, AstraZeneca, CAPGEMINI ENGINEERING, Hafnium Labs ApS, XtalPi Inc, Schrödinger, Charles River Laboratories, IQVIA Inc, Healx, Innoplexus, EVAXION BIOTECH A/S, Icometrix

What are the Application segmentation covered in the Intelligent Drug R-D Services Market report?

Ans: The Applications covered in the Intelligent Drug R-D Services Market report are Drug Discovery Research, Drug Development Research, Clinical Research

What are the Type segmentation covered in the Intelligent Drug R-D Services Market report?

Ans: The Types covered in the Intelligent Drug R-D Services Market report are Cloud Based, On-Premise

Recommended Reports

AI in Drug Discovery

AI Medical Diagnostics

Pharma Services & Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intelligent Drug R-D Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cloud Based
1.2.3 On-Premise
1.3 Market by Application
1.3.1 Global Intelligent Drug R-D Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery Research
1.3.3 Drug Development Research
1.3.4 Clinical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intelligent Drug R-D Services Market Perspective (2020-2031)
2.2 Global Intelligent Drug R-D Services Growth Trends by Region
2.2.1 Global Intelligent Drug R-D Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Intelligent Drug R-D Services Historic Market Size by Region (2020-2025)
2.2.3 Intelligent Drug R-D Services Forecasted Market Size by Region (2026-2031)
2.3 Intelligent Drug R-D Services Market Dynamics
2.3.1 Intelligent Drug R-D Services Industry Trends
2.3.2 Intelligent Drug R-D Services Market Drivers
2.3.3 Intelligent Drug R-D Services Market Challenges
2.3.4 Intelligent Drug R-D Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intelligent Drug R-D Services Players by Revenue
3.1.1 Global Top Intelligent Drug R-D Services Players by Revenue (2020-2025)
3.1.2 Global Intelligent Drug R-D Services Revenue Market Share by Players (2020-2025)
3.2 Global Intelligent Drug R-D Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Intelligent Drug R-D Services Revenue
3.4 Global Intelligent Drug R-D Services Market Concentration Ratio
3.4.1 Global Intelligent Drug R-D Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intelligent Drug R-D Services Revenue in 2024
3.5 Global Key Players of Intelligent Drug R-D Services Head office and Area Served
3.6 Global Key Players of Intelligent Drug R-D Services, Product and Application
3.7 Global Key Players of Intelligent Drug R-D Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Intelligent Drug R-D Services Breakdown Data by Type
4.1 Global Intelligent Drug R-D Services Historic Market Size by Type (2020-2025)
4.2 Global Intelligent Drug R-D Services Forecasted Market Size by Type (2026-2031)
5 Intelligent Drug R-D Services Breakdown Data by Application
5.1 Global Intelligent Drug R-D Services Historic Market Size by Application (2020-2025)
5.2 Global Intelligent Drug R-D Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Intelligent Drug R-D Services Market Size (2020-2031)
6.2 North America Intelligent Drug R-D Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Intelligent Drug R-D Services Market Size by Country (2020-2025)
6.4 North America Intelligent Drug R-D Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intelligent Drug R-D Services Market Size (2020-2031)
7.2 Europe Intelligent Drug R-D Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Intelligent Drug R-D Services Market Size by Country (2020-2025)
7.4 Europe Intelligent Drug R-D Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intelligent Drug R-D Services Market Size (2020-2031)
8.2 Asia-Pacific Intelligent Drug R-D Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Intelligent Drug R-D Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Intelligent Drug R-D Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intelligent Drug R-D Services Market Size (2020-2031)
9.2 Latin America Intelligent Drug R-D Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Intelligent Drug R-D Services Market Size by Country (2020-2025)
9.4 Latin America Intelligent Drug R-D Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intelligent Drug R-D Services Market Size (2020-2031)
10.2 Middle East & Africa Intelligent Drug R-D Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Intelligent Drug R-D Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Intelligent Drug R-D Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BenevolentAI
11.1.1 BenevolentAI Company Details
11.1.2 BenevolentAI Business Overview
11.1.3 BenevolentAI Intelligent Drug R-D Services Introduction
11.1.4 BenevolentAI Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.1.5 BenevolentAI Recent Development
11.2 Exscientia
11.2.1 Exscientia Company Details
11.2.2 Exscientia Business Overview
11.2.3 Exscientia Intelligent Drug R-D Services Introduction
11.2.4 Exscientia Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.2.5 Exscientia Recent Development
11.3 IBM
11.3.1 IBM Company Details
11.3.2 IBM Business Overview
11.3.3 IBM Intelligent Drug R-D Services Introduction
11.3.4 IBM Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.3.5 IBM Recent Development
11.4 Alphabet
11.4.1 Alphabet Company Details
11.4.2 Alphabet Business Overview
11.4.3 Alphabet Intelligent Drug R-D Services Introduction
11.4.4 Alphabet Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.4.5 Alphabet Recent Development
11.5 Berg Health
11.5.1 Berg Health Company Details
11.5.2 Berg Health Business Overview
11.5.3 Berg Health Intelligent Drug R-D Services Introduction
11.5.4 Berg Health Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.5.5 Berg Health Recent Development
11.6 Atomwise
11.6.1 Atomwise Company Details
11.6.2 Atomwise Business Overview
11.6.3 Atomwise Intelligent Drug R-D Services Introduction
11.6.4 Atomwise Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.6.5 Atomwise Recent Development
11.7 Insitro
11.7.1 Insitro Company Details
11.7.2 Insitro Business Overview
11.7.3 Insitro Intelligent Drug R-D Services Introduction
11.7.4 Insitro Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.7.5 Insitro Recent Development
11.8 Cyclica
11.8.1 Cyclica Company Details
11.8.2 Cyclica Business Overview
11.8.3 Cyclica Intelligent Drug R-D Services Introduction
11.8.4 Cyclica Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.8.5 Cyclica Recent Development
11.9 NVIDIA
11.9.1 NVIDIA Company Details
11.9.2 NVIDIA Business Overview
11.9.3 NVIDIA Intelligent Drug R-D Services Introduction
11.9.4 NVIDIA Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.9.5 NVIDIA Recent Development
11.10 Insilico Medicine
11.10.1 Insilico Medicine Company Details
11.10.2 Insilico Medicine Business Overview
11.10.3 Insilico Medicine Intelligent Drug R-D Services Introduction
11.10.4 Insilico Medicine Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.10.5 Insilico Medicine Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Intelligent Drug R-D Services Introduction
11.11.4 AstraZeneca Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.11.5 AstraZeneca Recent Development
11.12 CAPGEMINI ENGINEERING
11.12.1 CAPGEMINI ENGINEERING Company Details
11.12.2 CAPGEMINI ENGINEERING Business Overview
11.12.3 CAPGEMINI ENGINEERING Intelligent Drug R-D Services Introduction
11.12.4 CAPGEMINI ENGINEERING Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.12.5 CAPGEMINI ENGINEERING Recent Development
11.13 Hafnium Labs ApS
11.13.1 Hafnium Labs ApS Company Details
11.13.2 Hafnium Labs ApS Business Overview
11.13.3 Hafnium Labs ApS Intelligent Drug R-D Services Introduction
11.13.4 Hafnium Labs ApS Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.13.5 Hafnium Labs ApS Recent Development
11.14 XtalPi Inc
11.14.1 XtalPi Inc Company Details
11.14.2 XtalPi Inc Business Overview
11.14.3 XtalPi Inc Intelligent Drug R-D Services Introduction
11.14.4 XtalPi Inc Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.14.5 XtalPi Inc Recent Development
11.15 Schrödinger
11.15.1 Schrödinger Company Details
11.15.2 Schrödinger Business Overview
11.15.3 Schrödinger Intelligent Drug R-D Services Introduction
11.15.4 Schrödinger Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.15.5 Schrödinger Recent Development
11.16 Charles River Laboratories
11.16.1 Charles River Laboratories Company Details
11.16.2 Charles River Laboratories Business Overview
11.16.3 Charles River Laboratories Intelligent Drug R-D Services Introduction
11.16.4 Charles River Laboratories Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.16.5 Charles River Laboratories Recent Development
11.17 IQVIA Inc
11.17.1 IQVIA Inc Company Details
11.17.2 IQVIA Inc Business Overview
11.17.3 IQVIA Inc Intelligent Drug R-D Services Introduction
11.17.4 IQVIA Inc Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.17.5 IQVIA Inc Recent Development
11.18 Healx
11.18.1 Healx Company Details
11.18.2 Healx Business Overview
11.18.3 Healx Intelligent Drug R-D Services Introduction
11.18.4 Healx Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.18.5 Healx Recent Development
11.19 Innoplexus
11.19.1 Innoplexus Company Details
11.19.2 Innoplexus Business Overview
11.19.3 Innoplexus Intelligent Drug R-D Services Introduction
11.19.4 Innoplexus Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.19.5 Innoplexus Recent Development
11.20 EVAXION BIOTECH A/S
11.20.1 EVAXION BIOTECH A/S Company Details
11.20.2 EVAXION BIOTECH A/S Business Overview
11.20.3 EVAXION BIOTECH A/S Intelligent Drug R-D Services Introduction
11.20.4 EVAXION BIOTECH A/S Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.20.5 EVAXION BIOTECH A/S Recent Development
11.21 Icometrix
11.21.1 Icometrix Company Details
11.21.2 Icometrix Business Overview
11.21.3 Icometrix Intelligent Drug R-D Services Introduction
11.21.4 Icometrix Revenue in Intelligent Drug R-D Services Business (2020-2025)
11.21.5 Icometrix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
BenevolentAI
Exscientia Ltd
IBM
Alphabet
Berg Health
Atomwise
Insitro
Cyclica Inc
NVidia
InSilico Medicine
Astrazeneca plc
Capgemini Engineering
XtalPi
Schrödinger
Charles River Laboratories
IQVIA
Healx
Innoplexus
Icometrix
Hafnium Labs ApS
EVAXION BIOTECH A/S
List of Tables
 Table 1. Global Intelligent Drug R-D Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cloud Based
 Table 3. Key Players of On-Premise
 Table 4. Global Intelligent Drug R-D Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Intelligent Drug R-D Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Intelligent Drug R-D Services Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Intelligent Drug R-D Services Market Share by Region (2020-2025)
 Table 8. Global Intelligent Drug R-D Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Intelligent Drug R-D Services Market Share by Region (2026-2031)
 Table 10. Intelligent Drug R-D Services Market Trends
 Table 11. Intelligent Drug R-D Services Market Drivers
 Table 12. Intelligent Drug R-D Services Market Challenges
 Table 13. Intelligent Drug R-D Services Market Restraints
 Table 14. Global Intelligent Drug R-D Services Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Intelligent Drug R-D Services Market Share by Players (2020-2025)
 Table 16. Global Top Intelligent Drug R-D Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intelligent Drug R-D Services as of 2024)
 Table 17. Ranking of Global Top Intelligent Drug R-D Services Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Intelligent Drug R-D Services Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Intelligent Drug R-D Services, Headquarters and Area Served
 Table 20. Global Key Players of Intelligent Drug R-D Services, Product and Application
 Table 21. Global Key Players of Intelligent Drug R-D Services, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Intelligent Drug R-D Services Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Intelligent Drug R-D Services Revenue Market Share by Type (2020-2025)
 Table 25. Global Intelligent Drug R-D Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Intelligent Drug R-D Services Revenue Market Share by Type (2026-2031)
 Table 27. Global Intelligent Drug R-D Services Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Intelligent Drug R-D Services Revenue Market Share by Application (2020-2025)
 Table 29. Global Intelligent Drug R-D Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Intelligent Drug R-D Services Revenue Market Share by Application (2026-2031)
 Table 31. North America Intelligent Drug R-D Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Intelligent Drug R-D Services Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Intelligent Drug R-D Services Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Intelligent Drug R-D Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Intelligent Drug R-D Services Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Intelligent Drug R-D Services Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Intelligent Drug R-D Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Intelligent Drug R-D Services Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Intelligent Drug R-D Services Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intelligent Drug R-D Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Intelligent Drug R-D Services Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Intelligent Drug R-D Services Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Intelligent Drug R-D Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Intelligent Drug R-D Services Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Intelligent Drug R-D Services Market Size by Country (2026-2031) & (US$ Million)
 Table 46. BenevolentAI Company Details
 Table 47. BenevolentAI Business Overview
 Table 48. BenevolentAI Intelligent Drug R-D Services Product
 Table 49. BenevolentAI Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 50. BenevolentAI Recent Development
 Table 51. Exscientia Company Details
 Table 52. Exscientia Business Overview
 Table 53. Exscientia Intelligent Drug R-D Services Product
 Table 54. Exscientia Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 55. Exscientia Recent Development
 Table 56. IBM Company Details
 Table 57. IBM Business Overview
 Table 58. IBM Intelligent Drug R-D Services Product
 Table 59. IBM Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 60. IBM Recent Development
 Table 61. Alphabet Company Details
 Table 62. Alphabet Business Overview
 Table 63. Alphabet Intelligent Drug R-D Services Product
 Table 64. Alphabet Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 65. Alphabet Recent Development
 Table 66. Berg Health Company Details
 Table 67. Berg Health Business Overview
 Table 68. Berg Health Intelligent Drug R-D Services Product
 Table 69. Berg Health Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 70. Berg Health Recent Development
 Table 71. Atomwise Company Details
 Table 72. Atomwise Business Overview
 Table 73. Atomwise Intelligent Drug R-D Services Product
 Table 74. Atomwise Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 75. Atomwise Recent Development
 Table 76. Insitro Company Details
 Table 77. Insitro Business Overview
 Table 78. Insitro Intelligent Drug R-D Services Product
 Table 79. Insitro Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 80. Insitro Recent Development
 Table 81. Cyclica Company Details
 Table 82. Cyclica Business Overview
 Table 83. Cyclica Intelligent Drug R-D Services Product
 Table 84. Cyclica Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 85. Cyclica Recent Development
 Table 86. NVIDIA Company Details
 Table 87. NVIDIA Business Overview
 Table 88. NVIDIA Intelligent Drug R-D Services Product
 Table 89. NVIDIA Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 90. NVIDIA Recent Development
 Table 91. Insilico Medicine Company Details
 Table 92. Insilico Medicine Business Overview
 Table 93. Insilico Medicine Intelligent Drug R-D Services Product
 Table 94. Insilico Medicine Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 95. Insilico Medicine Recent Development
 Table 96. AstraZeneca Company Details
 Table 97. AstraZeneca Business Overview
 Table 98. AstraZeneca Intelligent Drug R-D Services Product
 Table 99. AstraZeneca Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 100. AstraZeneca Recent Development
 Table 101. CAPGEMINI ENGINEERING Company Details
 Table 102. CAPGEMINI ENGINEERING Business Overview
 Table 103. CAPGEMINI ENGINEERING Intelligent Drug R-D Services Product
 Table 104. CAPGEMINI ENGINEERING Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 105. CAPGEMINI ENGINEERING Recent Development
 Table 106. Hafnium Labs ApS Company Details
 Table 107. Hafnium Labs ApS Business Overview
 Table 108. Hafnium Labs ApS Intelligent Drug R-D Services Product
 Table 109. Hafnium Labs ApS Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 110. Hafnium Labs ApS Recent Development
 Table 111. XtalPi Inc Company Details
 Table 112. XtalPi Inc Business Overview
 Table 113. XtalPi Inc Intelligent Drug R-D Services Product
 Table 114. XtalPi Inc Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 115. XtalPi Inc Recent Development
 Table 116. Schrödinger Company Details
 Table 117. Schrödinger Business Overview
 Table 118. Schrödinger Intelligent Drug R-D Services Product
 Table 119. Schrödinger Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 120. Schrödinger Recent Development
 Table 121. Charles River Laboratories Company Details
 Table 122. Charles River Laboratories Business Overview
 Table 123. Charles River Laboratories Intelligent Drug R-D Services Product
 Table 124. Charles River Laboratories Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 125. Charles River Laboratories Recent Development
 Table 126. IQVIA Inc Company Details
 Table 127. IQVIA Inc Business Overview
 Table 128. IQVIA Inc Intelligent Drug R-D Services Product
 Table 129. IQVIA Inc Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 130. IQVIA Inc Recent Development
 Table 131. Healx Company Details
 Table 132. Healx Business Overview
 Table 133. Healx Intelligent Drug R-D Services Product
 Table 134. Healx Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 135. Healx Recent Development
 Table 136. Innoplexus Company Details
 Table 137. Innoplexus Business Overview
 Table 138. Innoplexus Intelligent Drug R-D Services Product
 Table 139. Innoplexus Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 140. Innoplexus Recent Development
 Table 141. EVAXION BIOTECH A/S Company Details
 Table 142. EVAXION BIOTECH A/S Business Overview
 Table 143. EVAXION BIOTECH A/S Intelligent Drug R-D Services Product
 Table 144. EVAXION BIOTECH A/S Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 145. EVAXION BIOTECH A/S Recent Development
 Table 146. Icometrix Company Details
 Table 147. Icometrix Business Overview
 Table 148. Icometrix Intelligent Drug R-D Services Product
 Table 149. Icometrix Revenue in Intelligent Drug R-D Services Business (2020-2025) & (US$ Million)
 Table 150. Icometrix Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. Intelligent Drug R-D Services Picture
 Figure 2. Global Intelligent Drug R-D Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intelligent Drug R-D Services Market Share by Type: 2024 VS 2031
 Figure 4. Cloud Based Features
 Figure 5. On-Premise Features
 Figure 6. Global Intelligent Drug R-D Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Intelligent Drug R-D Services Market Share by Application: 2024 VS 2031
 Figure 8. Drug Discovery Research Case Studies
 Figure 9. Drug Development Research Case Studies
 Figure 10. Clinical Research Case Studies
 Figure 11. Intelligent Drug R-D Services Report Years Considered
 Figure 12. Global Intelligent Drug R-D Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Intelligent Drug R-D Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Intelligent Drug R-D Services Market Share by Region: 2024 VS 2031
 Figure 15. Global Intelligent Drug R-D Services Market Share by Players in 2024
 Figure 16. Global Top Intelligent Drug R-D Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intelligent Drug R-D Services as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Intelligent Drug R-D Services Revenue in 2024
 Figure 18. North America Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Intelligent Drug R-D Services Market Share by Country (2020-2031)
 Figure 20. United States Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Intelligent Drug R-D Services Market Share by Country (2020-2031)
 Figure 24. Germany Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Intelligent Drug R-D Services Market Share by Region (2020-2031)
 Figure 32. China Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Intelligent Drug R-D Services Market Share by Country (2020-2031)
 Figure 40. Mexico Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Intelligent Drug R-D Services Market Share by Country (2020-2031)
 Figure 44. Turkey Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Intelligent Drug R-D Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. BenevolentAI Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 48. Exscientia Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 49. IBM Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 50. Alphabet Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 51. Berg Health Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 52. Atomwise Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 53. Insitro Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 54. Cyclica Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 55. NVIDIA Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 56. Insilico Medicine Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 57. AstraZeneca Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 58. CAPGEMINI ENGINEERING Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 59. Hafnium Labs ApS Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 60. XtalPi Inc Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 61. Schrödinger Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 62. Charles River Laboratories Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 63. IQVIA Inc Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 64. Healx Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 65. Innoplexus Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 66. EVAXION BIOTECH A/S Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 67. Icometrix Revenue Growth Rate in Intelligent Drug R-D Services Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Artificial Intelligence driven Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence AI in Biotechnology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI driven Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artificial Intelligence Drug R D Market Research Report 2024
Global Artificial Intelligence AI in Drug Discovery Market Insights Forecast to 2030
Global AI Technology in Pharmaceutical Market Research Report 2024
Artificial Intelligence AI in Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI for Drug Discovery and Development Market Research Report 2025
Global AI based Antibody Development Platform Market Research Report 2024
Artificial Intelligence For Drug Development and Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI for Pharma and Biotech Market Insights Forecast to 2030
Automation in Biopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Machine Learning in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence AI in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence in Drug Discovery and Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI based Clinical Trials Solution Provider Market Research Report 2024
Global Drug Discovery AI Tools Market Research Report 2025
AI Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Developing Platforms by Artificial Intelligence AI Market Research Report 2024
Artificial Intelligence AI in Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions